Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

1 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE) & Department of Neurology, Faculty of Medicine, University of Bonn;

2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;

3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);

2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;

3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);

2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;

3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);

3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);

2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;

4 Population Health Sciences, German Center for Neurodegenerative diseases (DZNE) & Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn